Medicaid spends more on antipsychotics –
including Eli Lilly’s (LLY) Zyprexa,
Bristol-Myers Squibb's (BMY) Abilify,
AstraZeneca’s (AZN) Seroquel and Johnson &
Johnson’s (JNJ) Risperdal - than any other class of medicine.
In 2008, the most recent year for which data was
available, spending was $3.6 billion, up from
$1.6 billion in 1999, according to Mathematica
Policy Research data cited by the paper. And the
number of people younger than 20 years old who
receive prescriptions for antipsychotics that are
paid for by Medicaid tripled during that period.
http://www.pharmalive.com/feds-probe-antipsychotic-prescriptions-for-children-in-medicaid?cid=nl.phrm01
"People Who experience mood swings, fear, voices and visions"